nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Daunorubicin—hematologic cancer	0.0322	0.0686	CbGbCtD
Vardenafil—CYP3A5—Thalidomide—hematologic cancer	0.0293	0.0625	CbGbCtD
Vardenafil—CYP3A5—Teniposide—hematologic cancer	0.028	0.0596	CbGbCtD
Vardenafil—CYP3A5—Ifosfamide—hematologic cancer	0.0258	0.055	CbGbCtD
Vardenafil—CYP3A5—Imatinib—hematologic cancer	0.0247	0.0525	CbGbCtD
Vardenafil—CYP3A4—Bexarotene—hematologic cancer	0.0214	0.0456	CbGbCtD
Vardenafil—CYP3A4—Lomustine—hematologic cancer	0.0199	0.0424	CbGbCtD
Vardenafil—CYP3A4—Busulfan—hematologic cancer	0.0199	0.0424	CbGbCtD
Vardenafil—CYP3A5—Dasatinib—hematologic cancer	0.0198	0.0422	CbGbCtD
Vardenafil—CYP3A4—Thiotepa—hematologic cancer	0.0178	0.0378	CbGbCtD
Vardenafil—CYP3A5—Irinotecan—hematologic cancer	0.0154	0.0328	CbGbCtD
Vardenafil—CYP3A4—Methoxsalen—hematologic cancer	0.0138	0.0294	CbGbCtD
Vardenafil—CYP3A5—Vincristine—hematologic cancer	0.0135	0.0287	CbGbCtD
Vardenafil—CYP3A4—Bortezomib—hematologic cancer	0.0131	0.028	CbGbCtD
Vardenafil—CYP3A4—Daunorubicin—hematologic cancer	0.0126	0.0267	CbGbCtD
Vardenafil—CYP3A5—Etoposide—hematologic cancer	0.0123	0.0263	CbGbCtD
Vardenafil—CYP3A4—Cytarabine—hematologic cancer	0.0111	0.0236	CbGbCtD
Vardenafil—CYP3A4—Teniposide—hematologic cancer	0.0109	0.0232	CbGbCtD
Vardenafil—CYP3A5—Dexamethasone—hematologic cancer	0.0102	0.0216	CbGbCtD
Vardenafil—CYP3A4—Ifosfamide—hematologic cancer	0.0101	0.0214	CbGbCtD
Vardenafil—CYP3A4—Imatinib—hematologic cancer	0.00962	0.0205	CbGbCtD
Vardenafil—CYP3A4—Ruxolitinib—hematologic cancer	0.00906	0.0193	CbGbCtD
Vardenafil—CYP3A4—Nilotinib—hematologic cancer	0.00875	0.0186	CbGbCtD
Vardenafil—CYP3A4—Vinorelbine—hematologic cancer	0.00867	0.0185	CbGbCtD
Vardenafil—CYP3A4—Triamcinolone—hematologic cancer	0.00793	0.0169	CbGbCtD
Vardenafil—CYP3A4—Dasatinib—hematologic cancer	0.00773	0.0165	CbGbCtD
Vardenafil—CYP3A4—Mitoxantrone—hematologic cancer	0.00763	0.0162	CbGbCtD
Vardenafil—CYP3A4—Betamethasone—hematologic cancer	0.00681	0.0145	CbGbCtD
Vardenafil—CYP3A4—Prednisolone—hematologic cancer	0.00671	0.0143	CbGbCtD
Vardenafil—CYP3A4—Prednisone—hematologic cancer	0.00634	0.0135	CbGbCtD
Vardenafil—CYP3A4—Irinotecan—hematologic cancer	0.00601	0.0128	CbGbCtD
Vardenafil—CYP3A4—Vinblastine—hematologic cancer	0.00534	0.0114	CbGbCtD
Vardenafil—CYP3A4—Vincristine—hematologic cancer	0.00525	0.0112	CbGbCtD
Vardenafil—PDE6G—blood—hematologic cancer	0.00506	0.0882	CbGeAlD
Vardenafil—CYP3A4—Etoposide—hematologic cancer	0.00481	0.0102	CbGbCtD
Vardenafil—PDE6G—lung—hematologic cancer	0.00444	0.0773	CbGeAlD
Vardenafil—PDE11A—testis—hematologic cancer	0.00435	0.0758	CbGeAlD
Vardenafil—PDE6G—testis—hematologic cancer	0.00419	0.073	CbGeAlD
Vardenafil—CYP3A4—Dexamethasone—hematologic cancer	0.00396	0.00842	CbGbCtD
Vardenafil—PDE1B—gonad—hematologic cancer	0.00389	0.0678	CbGeAlD
Vardenafil—PDE1B—blood—hematologic cancer	0.00339	0.0591	CbGeAlD
Vardenafil—CYP3A4—Doxorubicin—hematologic cancer	0.00328	0.00699	CbGbCtD
Vardenafil—PDE6G—lymph node—hematologic cancer	0.00303	0.0529	CbGeAlD
Vardenafil—PDE5A—hematopoietic system—hematologic cancer	0.00302	0.0526	CbGeAlD
Vardenafil—PDE10A—lung—hematologic cancer	0.003	0.0522	CbGeAlD
Vardenafil—PDE10A—testis—hematologic cancer	0.00283	0.0493	CbGeAlD
Vardenafil—PDE1B—testis—hematologic cancer	0.0028	0.0489	CbGeAlD
Vardenafil—PDE5A—gonad—hematologic cancer	0.0023	0.04	CbGeAlD
Vardenafil—PDE10A—lymph node—hematologic cancer	0.00205	0.0357	CbGeAlD
Vardenafil—PDE1B—lymph node—hematologic cancer	0.00203	0.0354	CbGeAlD
Vardenafil—PDE5A—blood—hematologic cancer	0.002	0.0349	CbGeAlD
Vardenafil—PDE5A—lung—hematologic cancer	0.00175	0.0306	CbGeAlD
Vardenafil—PDE5A—testis—hematologic cancer	0.00165	0.0288	CbGeAlD
Vardenafil—CYP3A5—hematopoietic system—hematologic cancer	0.00125	0.0219	CbGeAlD
Vardenafil—PDE5A—lymph node—hematologic cancer	0.0012	0.0209	CbGeAlD
Vardenafil—CYP3A4—hematopoietic system—hematologic cancer	0.000941	0.0164	CbGeAlD
Vardenafil—CYP3A5—blood—hematologic cancer	0.000831	0.0145	CbGeAlD
Vardenafil—CYP3A5—lung—hematologic cancer	0.000728	0.0127	CbGeAlD
Vardenafil—CYP3A4—blood—hematologic cancer	0.000623	0.0109	CbGeAlD
Vardenafil—Discomfort—Prednisone—hematologic cancer	4.11e-05	0.000131	CcSEcCtD
Vardenafil—Mental disorder—Methotrexate—hematologic cancer	4.11e-05	0.000131	CcSEcCtD
Vardenafil—Rash—Gemcitabine—hematologic cancer	4.11e-05	0.000131	CcSEcCtD
Vardenafil—Dermatitis—Gemcitabine—hematologic cancer	4.1e-05	0.000131	CcSEcCtD
Vardenafil—Eye disorder—Epirubicin—hematologic cancer	4.1e-05	0.000131	CcSEcCtD
Vardenafil—Hypersensitivity—Etoposide—hematologic cancer	4.1e-05	0.00013	CcSEcCtD
Vardenafil—Tinnitus—Epirubicin—hematologic cancer	4.09e-05	0.00013	CcSEcCtD
Vardenafil—Erythema—Methotrexate—hematologic cancer	4.08e-05	0.00013	CcSEcCtD
Vardenafil—Haemoglobin—Doxorubicin—hematologic cancer	4.08e-05	0.00013	CcSEcCtD
Vardenafil—Headache—Gemcitabine—hematologic cancer	4.08e-05	0.00013	CcSEcCtD
Vardenafil—Nausea—Vincristine—hematologic cancer	4.08e-05	0.00013	CcSEcCtD
Vardenafil—Flushing—Epirubicin—hematologic cancer	4.07e-05	0.00013	CcSEcCtD
Vardenafil—Cardiac disorder—Epirubicin—hematologic cancer	4.07e-05	0.00013	CcSEcCtD
Vardenafil—Rhinitis—Doxorubicin—hematologic cancer	4.07e-05	0.00013	CcSEcCtD
Vardenafil—Haemorrhage—Doxorubicin—hematologic cancer	4.06e-05	0.000129	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisolone—hematologic cancer	4.04e-05	0.000129	CcSEcCtD
Vardenafil—Hypoaesthesia—Doxorubicin—hematologic cancer	4.04e-05	0.000129	CcSEcCtD
Vardenafil—Pharyngitis—Doxorubicin—hematologic cancer	4.03e-05	0.000128	CcSEcCtD
Vardenafil—Dyspepsia—Dexamethasone—hematologic cancer	4.03e-05	0.000128	CcSEcCtD
Vardenafil—Dyspepsia—Betamethasone—hematologic cancer	4.03e-05	0.000128	CcSEcCtD
Vardenafil—Urinary tract disorder—Doxorubicin—hematologic cancer	4.01e-05	0.000128	CcSEcCtD
Vardenafil—Asthenia—Etoposide—hematologic cancer	3.99e-05	0.000127	CcSEcCtD
Vardenafil—Connective tissue disorder—Doxorubicin—hematologic cancer	3.99e-05	0.000127	CcSEcCtD
Vardenafil—Anaphylactic shock—Prednisone—hematologic cancer	3.99e-05	0.000127	CcSEcCtD
Vardenafil—Angiopathy—Epirubicin—hematologic cancer	3.98e-05	0.000127	CcSEcCtD
Vardenafil—Urethral disorder—Doxorubicin—hematologic cancer	3.98e-05	0.000127	CcSEcCtD
Vardenafil—Nausea—Mitoxantrone—hematologic cancer	3.97e-05	0.000126	CcSEcCtD
Vardenafil—Nausea—Irinotecan—hematologic cancer	3.97e-05	0.000126	CcSEcCtD
Vardenafil—Immune system disorder—Epirubicin—hematologic cancer	3.96e-05	0.000126	CcSEcCtD
Vardenafil—Infection—Prednisone—hematologic cancer	3.96e-05	0.000126	CcSEcCtD
Vardenafil—Mediastinal disorder—Epirubicin—hematologic cancer	3.95e-05	0.000126	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.95e-05	0.000126	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.95e-05	0.000126	CcSEcCtD
Vardenafil—Back pain—Methotrexate—hematologic cancer	3.95e-05	0.000126	CcSEcCtD
Vardenafil—Pruritus—Etoposide—hematologic cancer	3.93e-05	0.000125	CcSEcCtD
Vardenafil—Shock—Prednisone—hematologic cancer	3.92e-05	0.000125	CcSEcCtD
Vardenafil—Pain—Dexamethasone—hematologic cancer	3.91e-05	0.000125	CcSEcCtD
Vardenafil—Pain—Betamethasone—hematologic cancer	3.91e-05	0.000125	CcSEcCtD
Vardenafil—Visual impairment—Doxorubicin—hematologic cancer	3.91e-05	0.000125	CcSEcCtD
Vardenafil—Nervous system disorder—Prednisone—hematologic cancer	3.91e-05	0.000124	CcSEcCtD
Vardenafil—Tachycardia—Prednisone—hematologic cancer	3.89e-05	0.000124	CcSEcCtD
Vardenafil—Skin disorder—Prednisone—hematologic cancer	3.87e-05	0.000123	CcSEcCtD
Vardenafil—Nausea—Gemcitabine—hematologic cancer	3.87e-05	0.000123	CcSEcCtD
Vardenafil—Vomiting—Cisplatin—hematologic cancer	3.86e-05	0.000123	CcSEcCtD
Vardenafil—Hyperhidrosis—Prednisone—hematologic cancer	3.85e-05	0.000123	CcSEcCtD
Vardenafil—Vision blurred—Methotrexate—hematologic cancer	3.85e-05	0.000122	CcSEcCtD
Vardenafil—Mental disorder—Epirubicin—hematologic cancer	3.84e-05	0.000122	CcSEcCtD
Vardenafil—Rash—Cisplatin—hematologic cancer	3.83e-05	0.000122	CcSEcCtD
Vardenafil—Dermatitis—Cisplatin—hematologic cancer	3.82e-05	0.000122	CcSEcCtD
Vardenafil—Erythema—Epirubicin—hematologic cancer	3.82e-05	0.000122	CcSEcCtD
Vardenafil—Diarrhoea—Etoposide—hematologic cancer	3.8e-05	0.000121	CcSEcCtD
Vardenafil—Eye disorder—Doxorubicin—hematologic cancer	3.79e-05	0.000121	CcSEcCtD
Vardenafil—Ill-defined disorder—Methotrexate—hematologic cancer	3.79e-05	0.000121	CcSEcCtD
Vardenafil—Tinnitus—Doxorubicin—hematologic cancer	3.78e-05	0.000121	CcSEcCtD
Vardenafil—Feeling abnormal—Betamethasone—hematologic cancer	3.77e-05	0.00012	CcSEcCtD
Vardenafil—Feeling abnormal—Dexamethasone—hematologic cancer	3.77e-05	0.00012	CcSEcCtD
Vardenafil—Cardiac disorder—Doxorubicin—hematologic cancer	3.77e-05	0.00012	CcSEcCtD
Vardenafil—Flushing—Doxorubicin—hematologic cancer	3.77e-05	0.00012	CcSEcCtD
Vardenafil—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.74e-05	0.000119	CcSEcCtD
Vardenafil—Gastrointestinal pain—Betamethasone—hematologic cancer	3.74e-05	0.000119	CcSEcCtD
Vardenafil—Hypersensitivity—Triamcinolone—hematologic cancer	3.72e-05	0.000118	CcSEcCtD
Vardenafil—Back pain—Epirubicin—hematologic cancer	3.69e-05	0.000118	CcSEcCtD
Vardenafil—Angiopathy—Doxorubicin—hematologic cancer	3.68e-05	0.000117	CcSEcCtD
Vardenafil—Malaise—Methotrexate—hematologic cancer	3.68e-05	0.000117	CcSEcCtD
Vardenafil—Dizziness—Etoposide—hematologic cancer	3.68e-05	0.000117	CcSEcCtD
Vardenafil—Muscle spasms—Epirubicin—hematologic cancer	3.67e-05	0.000117	CcSEcCtD
Vardenafil—Immune system disorder—Doxorubicin—hematologic cancer	3.67e-05	0.000117	CcSEcCtD
Vardenafil—Vertigo—Methotrexate—hematologic cancer	3.67e-05	0.000117	CcSEcCtD
Vardenafil—Mediastinal disorder—Doxorubicin—hematologic cancer	3.66e-05	0.000116	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.63e-05	0.000116	CcSEcCtD
Vardenafil—Dizziness—Prednisolone—hematologic cancer	3.63e-05	0.000115	CcSEcCtD
Vardenafil—Asthenia—Triamcinolone—hematologic cancer	3.62e-05	0.000115	CcSEcCtD
Vardenafil—Abdominal pain—Dexamethasone—hematologic cancer	3.62e-05	0.000115	CcSEcCtD
Vardenafil—Abdominal pain—Betamethasone—hematologic cancer	3.62e-05	0.000115	CcSEcCtD
Vardenafil—Nausea—Cisplatin—hematologic cancer	3.61e-05	0.000115	CcSEcCtD
Vardenafil—Insomnia—Prednisone—hematologic cancer	3.6e-05	0.000115	CcSEcCtD
Vardenafil—Vision blurred—Epirubicin—hematologic cancer	3.6e-05	0.000115	CcSEcCtD
Vardenafil—Paraesthesia—Prednisone—hematologic cancer	3.58e-05	0.000114	CcSEcCtD
Vardenafil—Pruritus—Triamcinolone—hematologic cancer	3.57e-05	0.000114	CcSEcCtD
Vardenafil—Mental disorder—Doxorubicin—hematologic cancer	3.56e-05	0.000113	CcSEcCtD
Vardenafil—Ill-defined disorder—Epirubicin—hematologic cancer	3.54e-05	0.000113	CcSEcCtD
Vardenafil—Convulsion—Methotrexate—hematologic cancer	3.54e-05	0.000113	CcSEcCtD
Vardenafil—Vomiting—Etoposide—hematologic cancer	3.54e-05	0.000113	CcSEcCtD
Vardenafil—Erythema—Doxorubicin—hematologic cancer	3.53e-05	0.000113	CcSEcCtD
Vardenafil—Dyspepsia—Prednisone—hematologic cancer	3.51e-05	0.000112	CcSEcCtD
Vardenafil—Rash—Etoposide—hematologic cancer	3.51e-05	0.000112	CcSEcCtD
Vardenafil—Dermatitis—Etoposide—hematologic cancer	3.5e-05	0.000112	CcSEcCtD
Vardenafil—Headache—Etoposide—hematologic cancer	3.48e-05	0.000111	CcSEcCtD
Vardenafil—Arthralgia—Methotrexate—hematologic cancer	3.47e-05	0.000111	CcSEcCtD
Vardenafil—Chest pain—Methotrexate—hematologic cancer	3.47e-05	0.000111	CcSEcCtD
Vardenafil—Myalgia—Methotrexate—hematologic cancer	3.47e-05	0.000111	CcSEcCtD
Vardenafil—Rash—Prednisolone—hematologic cancer	3.46e-05	0.00011	CcSEcCtD
Vardenafil—Dermatitis—Prednisolone—hematologic cancer	3.45e-05	0.00011	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.45e-05	0.00011	CcSEcCtD
Vardenafil—Malaise—Epirubicin—hematologic cancer	3.44e-05	0.00011	CcSEcCtD
Vardenafil—Headache—Prednisolone—hematologic cancer	3.44e-05	0.000109	CcSEcCtD
Vardenafil—Discomfort—Methotrexate—hematologic cancer	3.43e-05	0.000109	CcSEcCtD
Vardenafil—Vertigo—Epirubicin—hematologic cancer	3.43e-05	0.000109	CcSEcCtD
Vardenafil—Syncope—Epirubicin—hematologic cancer	3.43e-05	0.000109	CcSEcCtD
Vardenafil—Back pain—Doxorubicin—hematologic cancer	3.42e-05	0.000109	CcSEcCtD
Vardenafil—Muscle spasms—Doxorubicin—hematologic cancer	3.4e-05	0.000108	CcSEcCtD
Vardenafil—Palpitations—Epirubicin—hematologic cancer	3.38e-05	0.000107	CcSEcCtD
Vardenafil—Loss of consciousness—Epirubicin—hematologic cancer	3.36e-05	0.000107	CcSEcCtD
Vardenafil—Dizziness—Triamcinolone—hematologic cancer	3.34e-05	0.000106	CcSEcCtD
Vardenafil—Anaphylactic shock—Methotrexate—hematologic cancer	3.33e-05	0.000106	CcSEcCtD
Vardenafil—Vision blurred—Doxorubicin—hematologic cancer	3.33e-05	0.000106	CcSEcCtD
Vardenafil—Convulsion—Epirubicin—hematologic cancer	3.31e-05	0.000105	CcSEcCtD
Vardenafil—Infection—Methotrexate—hematologic cancer	3.31e-05	0.000105	CcSEcCtD
Vardenafil—Nausea—Etoposide—hematologic cancer	3.3e-05	0.000105	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisone—hematologic cancer	3.28e-05	0.000105	CcSEcCtD
Vardenafil—Asthenia—Betamethasone—hematologic cancer	3.28e-05	0.000105	CcSEcCtD
Vardenafil—Asthenia—Dexamethasone—hematologic cancer	3.28e-05	0.000105	CcSEcCtD
Vardenafil—Ill-defined disorder—Doxorubicin—hematologic cancer	3.28e-05	0.000104	CcSEcCtD
Vardenafil—Nervous system disorder—Methotrexate—hematologic cancer	3.27e-05	0.000104	CcSEcCtD
Vardenafil—Gastrointestinal pain—Prednisone—hematologic cancer	3.26e-05	0.000104	CcSEcCtD
Vardenafil—Nausea—Prednisolone—hematologic cancer	3.26e-05	0.000104	CcSEcCtD
Vardenafil—Myalgia—Epirubicin—hematologic cancer	3.25e-05	0.000104	CcSEcCtD
Vardenafil—Chest pain—Epirubicin—hematologic cancer	3.25e-05	0.000104	CcSEcCtD
Vardenafil—Arthralgia—Epirubicin—hematologic cancer	3.25e-05	0.000104	CcSEcCtD
Vardenafil—Anxiety—Epirubicin—hematologic cancer	3.24e-05	0.000103	CcSEcCtD
Vardenafil—Pruritus—Dexamethasone—hematologic cancer	3.24e-05	0.000103	CcSEcCtD
Vardenafil—Pruritus—Betamethasone—hematologic cancer	3.24e-05	0.000103	CcSEcCtD
Vardenafil—Skin disorder—Methotrexate—hematologic cancer	3.24e-05	0.000103	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.23e-05	0.000103	CcSEcCtD
Vardenafil—Hyperhidrosis—Methotrexate—hematologic cancer	3.22e-05	0.000103	CcSEcCtD
Vardenafil—Discomfort—Epirubicin—hematologic cancer	3.21e-05	0.000102	CcSEcCtD
Vardenafil—Vomiting—Triamcinolone—hematologic cancer	3.21e-05	0.000102	CcSEcCtD
Vardenafil—Malaise—Doxorubicin—hematologic cancer	3.19e-05	0.000101	CcSEcCtD
Vardenafil—Rash—Triamcinolone—hematologic cancer	3.18e-05	0.000101	CcSEcCtD
Vardenafil—Dry mouth—Epirubicin—hematologic cancer	3.18e-05	0.000101	CcSEcCtD
Vardenafil—Dermatitis—Triamcinolone—hematologic cancer	3.18e-05	0.000101	CcSEcCtD
Vardenafil—Vertigo—Doxorubicin—hematologic cancer	3.17e-05	0.000101	CcSEcCtD
Vardenafil—Syncope—Doxorubicin—hematologic cancer	3.17e-05	0.000101	CcSEcCtD
Vardenafil—Headache—Triamcinolone—hematologic cancer	3.16e-05	0.000101	CcSEcCtD
Vardenafil—Abdominal pain—Prednisone—hematologic cancer	3.15e-05	0.0001	CcSEcCtD
Vardenafil—Diarrhoea—Betamethasone—hematologic cancer	3.13e-05	9.97e-05	CcSEcCtD
Vardenafil—Diarrhoea—Dexamethasone—hematologic cancer	3.13e-05	9.97e-05	CcSEcCtD
Vardenafil—Palpitations—Doxorubicin—hematologic cancer	3.12e-05	9.94e-05	CcSEcCtD
Vardenafil—Anaphylactic shock—Epirubicin—hematologic cancer	3.12e-05	9.92e-05	CcSEcCtD
Vardenafil—Hypotension—Methotrexate—hematologic cancer	3.11e-05	9.91e-05	CcSEcCtD
Vardenafil—Loss of consciousness—Doxorubicin—hematologic cancer	3.11e-05	9.89e-05	CcSEcCtD
Vardenafil—Infection—Epirubicin—hematologic cancer	3.1e-05	9.86e-05	CcSEcCtD
Vardenafil—Shock—Epirubicin—hematologic cancer	3.07e-05	9.76e-05	CcSEcCtD
Vardenafil—Convulsion—Doxorubicin—hematologic cancer	3.06e-05	9.75e-05	CcSEcCtD
Vardenafil—Nervous system disorder—Epirubicin—hematologic cancer	3.06e-05	9.73e-05	CcSEcCtD
Vardenafil—Tachycardia—Epirubicin—hematologic cancer	3.04e-05	9.69e-05	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.03e-05	9.66e-05	CcSEcCtD
Vardenafil—Skin disorder—Epirubicin—hematologic cancer	3.03e-05	9.64e-05	CcSEcCtD
Vardenafil—Dizziness—Betamethasone—hematologic cancer	3.03e-05	9.64e-05	CcSEcCtD
Vardenafil—Dizziness—Dexamethasone—hematologic cancer	3.03e-05	9.64e-05	CcSEcCtD
Vardenafil—Hyperhidrosis—Epirubicin—hematologic cancer	3.01e-05	9.59e-05	CcSEcCtD
Vardenafil—Insomnia—Methotrexate—hematologic cancer	3.01e-05	9.59e-05	CcSEcCtD
Vardenafil—Myalgia—Doxorubicin—hematologic cancer	3.01e-05	9.58e-05	CcSEcCtD
Vardenafil—Chest pain—Doxorubicin—hematologic cancer	3.01e-05	9.58e-05	CcSEcCtD
Vardenafil—Arthralgia—Doxorubicin—hematologic cancer	3.01e-05	9.58e-05	CcSEcCtD
Vardenafil—Anxiety—Doxorubicin—hematologic cancer	3e-05	9.55e-05	CcSEcCtD
Vardenafil—Nausea—Triamcinolone—hematologic cancer	3e-05	9.54e-05	CcSEcCtD
Vardenafil—Paraesthesia—Methotrexate—hematologic cancer	2.99e-05	9.52e-05	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.99e-05	9.51e-05	CcSEcCtD
Vardenafil—Discomfort—Doxorubicin—hematologic cancer	2.97e-05	9.46e-05	CcSEcCtD
Vardenafil—Dyspnoea—Methotrexate—hematologic cancer	2.97e-05	9.45e-05	CcSEcCtD
Vardenafil—Somnolence—Methotrexate—hematologic cancer	2.96e-05	9.43e-05	CcSEcCtD
Vardenafil—Dry mouth—Doxorubicin—hematologic cancer	2.94e-05	9.37e-05	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisone—hematologic cancer	2.94e-05	9.35e-05	CcSEcCtD
Vardenafil—Dyspepsia—Methotrexate—hematologic cancer	2.93e-05	9.34e-05	CcSEcCtD
Vardenafil—Hypotension—Epirubicin—hematologic cancer	2.91e-05	9.27e-05	CcSEcCtD
Vardenafil—Vomiting—Betamethasone—hematologic cancer	2.91e-05	9.26e-05	CcSEcCtD
Vardenafil—Vomiting—Dexamethasone—hematologic cancer	2.91e-05	9.26e-05	CcSEcCtD
Vardenafil—Rash—Dexamethasone—hematologic cancer	2.89e-05	9.19e-05	CcSEcCtD
Vardenafil—Rash—Betamethasone—hematologic cancer	2.89e-05	9.19e-05	CcSEcCtD
Vardenafil—Anaphylactic shock—Doxorubicin—hematologic cancer	2.88e-05	9.18e-05	CcSEcCtD
Vardenafil—Dermatitis—Dexamethasone—hematologic cancer	2.88e-05	9.18e-05	CcSEcCtD
Vardenafil—Dermatitis—Betamethasone—hematologic cancer	2.88e-05	9.18e-05	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.88e-05	9.16e-05	CcSEcCtD
Vardenafil—Headache—Betamethasone—hematologic cancer	2.87e-05	9.13e-05	CcSEcCtD
Vardenafil—Headache—Dexamethasone—hematologic cancer	2.87e-05	9.13e-05	CcSEcCtD
Vardenafil—Infection—Doxorubicin—hematologic cancer	2.87e-05	9.12e-05	CcSEcCtD
Vardenafil—Asthenia—Prednisone—hematologic cancer	2.86e-05	9.1e-05	CcSEcCtD
Vardenafil—Pain—Methotrexate—hematologic cancer	2.85e-05	9.07e-05	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.84e-05	9.04e-05	CcSEcCtD
Vardenafil—Shock—Doxorubicin—hematologic cancer	2.84e-05	9.03e-05	CcSEcCtD
Vardenafil—Nervous system disorder—Doxorubicin—hematologic cancer	2.83e-05	9.01e-05	CcSEcCtD
Vardenafil—Pruritus—Prednisone—hematologic cancer	2.82e-05	8.98e-05	CcSEcCtD
Vardenafil—Insomnia—Epirubicin—hematologic cancer	2.82e-05	8.98e-05	CcSEcCtD
Vardenafil—Tachycardia—Doxorubicin—hematologic cancer	2.81e-05	8.96e-05	CcSEcCtD
Vardenafil—Skin disorder—Doxorubicin—hematologic cancer	2.8e-05	8.92e-05	CcSEcCtD
Vardenafil—Paraesthesia—Epirubicin—hematologic cancer	2.8e-05	8.91e-05	CcSEcCtD
Vardenafil—Hyperhidrosis—Doxorubicin—hematologic cancer	2.79e-05	8.88e-05	CcSEcCtD
Vardenafil—Dyspnoea—Epirubicin—hematologic cancer	2.78e-05	8.85e-05	CcSEcCtD
Vardenafil—Somnolence—Epirubicin—hematologic cancer	2.77e-05	8.82e-05	CcSEcCtD
Vardenafil—Feeling abnormal—Methotrexate—hematologic cancer	2.74e-05	8.74e-05	CcSEcCtD
Vardenafil—Dyspepsia—Epirubicin—hematologic cancer	2.74e-05	8.74e-05	CcSEcCtD
Vardenafil—Diarrhoea—Prednisone—hematologic cancer	2.73e-05	8.68e-05	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methotrexate—hematologic cancer	2.72e-05	8.67e-05	CcSEcCtD
Vardenafil—Nausea—Betamethasone—hematologic cancer	2.72e-05	8.66e-05	CcSEcCtD
Vardenafil—Nausea—Dexamethasone—hematologic cancer	2.72e-05	8.66e-05	CcSEcCtD
Vardenafil—Hypotension—Doxorubicin—hematologic cancer	2.7e-05	8.58e-05	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.69e-05	8.57e-05	CcSEcCtD
Vardenafil—Pain—Epirubicin—hematologic cancer	2.67e-05	8.49e-05	CcSEcCtD
Vardenafil—Dizziness—Prednisone—hematologic cancer	2.64e-05	8.39e-05	CcSEcCtD
Vardenafil—Abdominal pain—Methotrexate—hematologic cancer	2.63e-05	8.38e-05	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.63e-05	8.37e-05	CcSEcCtD
Vardenafil—Insomnia—Doxorubicin—hematologic cancer	2.61e-05	8.31e-05	CcSEcCtD
Vardenafil—Paraesthesia—Doxorubicin—hematologic cancer	2.59e-05	8.25e-05	CcSEcCtD
Vardenafil—Dyspnoea—Doxorubicin—hematologic cancer	2.57e-05	8.19e-05	CcSEcCtD
Vardenafil—Feeling abnormal—Epirubicin—hematologic cancer	2.57e-05	8.18e-05	CcSEcCtD
Vardenafil—Somnolence—Doxorubicin—hematologic cancer	2.56e-05	8.16e-05	CcSEcCtD
Vardenafil—Gastrointestinal pain—Epirubicin—hematologic cancer	2.55e-05	8.12e-05	CcSEcCtD
Vardenafil—Dyspepsia—Doxorubicin—hematologic cancer	2.54e-05	8.08e-05	CcSEcCtD
Vardenafil—Vomiting—Prednisone—hematologic cancer	2.53e-05	8.07e-05	CcSEcCtD
Vardenafil—Rash—Prednisone—hematologic cancer	2.51e-05	8e-05	CcSEcCtD
Vardenafil—Dermatitis—Prednisone—hematologic cancer	2.51e-05	7.99e-05	CcSEcCtD
Vardenafil—Headache—Prednisone—hematologic cancer	2.5e-05	7.95e-05	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.49e-05	7.93e-05	CcSEcCtD
Vardenafil—Pain—Doxorubicin—hematologic cancer	2.47e-05	7.85e-05	CcSEcCtD
Vardenafil—Abdominal pain—Epirubicin—hematologic cancer	2.46e-05	7.85e-05	CcSEcCtD
Vardenafil—Hypersensitivity—Methotrexate—hematologic cancer	2.45e-05	7.81e-05	CcSEcCtD
Vardenafil—Asthenia—Methotrexate—hematologic cancer	2.39e-05	7.61e-05	CcSEcCtD
Vardenafil—Feeling abnormal—Doxorubicin—hematologic cancer	2.38e-05	7.57e-05	CcSEcCtD
Vardenafil—Nausea—Prednisone—hematologic cancer	2.37e-05	7.54e-05	CcSEcCtD
Vardenafil—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.36e-05	7.51e-05	CcSEcCtD
Vardenafil—Pruritus—Methotrexate—hematologic cancer	2.36e-05	7.5e-05	CcSEcCtD
Vardenafil—Hypersensitivity—Epirubicin—hematologic cancer	2.3e-05	7.31e-05	CcSEcCtD
Vardenafil—Abdominal pain—Doxorubicin—hematologic cancer	2.28e-05	7.26e-05	CcSEcCtD
Vardenafil—Diarrhoea—Methotrexate—hematologic cancer	2.28e-05	7.26e-05	CcSEcCtD
Vardenafil—Asthenia—Epirubicin—hematologic cancer	2.24e-05	7.12e-05	CcSEcCtD
Vardenafil—Pruritus—Epirubicin—hematologic cancer	2.21e-05	7.02e-05	CcSEcCtD
Vardenafil—Dizziness—Methotrexate—hematologic cancer	2.2e-05	7.01e-05	CcSEcCtD
Vardenafil—Diarrhoea—Epirubicin—hematologic cancer	2.13e-05	6.79e-05	CcSEcCtD
Vardenafil—Hypersensitivity—Doxorubicin—hematologic cancer	2.12e-05	6.77e-05	CcSEcCtD
Vardenafil—Vomiting—Methotrexate—hematologic cancer	2.12e-05	6.74e-05	CcSEcCtD
Vardenafil—Rash—Methotrexate—hematologic cancer	2.1e-05	6.69e-05	CcSEcCtD
Vardenafil—Dermatitis—Methotrexate—hematologic cancer	2.1e-05	6.68e-05	CcSEcCtD
Vardenafil—Headache—Methotrexate—hematologic cancer	2.09e-05	6.64e-05	CcSEcCtD
Vardenafil—Asthenia—Doxorubicin—hematologic cancer	2.07e-05	6.59e-05	CcSEcCtD
Vardenafil—Dizziness—Epirubicin—hematologic cancer	2.06e-05	6.56e-05	CcSEcCtD
Vardenafil—Pruritus—Doxorubicin—hematologic cancer	2.04e-05	6.5e-05	CcSEcCtD
Vardenafil—Vomiting—Epirubicin—hematologic cancer	1.98e-05	6.31e-05	CcSEcCtD
Vardenafil—Nausea—Methotrexate—hematologic cancer	1.98e-05	6.3e-05	CcSEcCtD
Vardenafil—Diarrhoea—Doxorubicin—hematologic cancer	1.97e-05	6.28e-05	CcSEcCtD
Vardenafil—Rash—Epirubicin—hematologic cancer	1.97e-05	6.26e-05	CcSEcCtD
Vardenafil—Dermatitis—Epirubicin—hematologic cancer	1.96e-05	6.25e-05	CcSEcCtD
Vardenafil—Headache—Epirubicin—hematologic cancer	1.95e-05	6.22e-05	CcSEcCtD
Vardenafil—Dizziness—Doxorubicin—hematologic cancer	1.91e-05	6.07e-05	CcSEcCtD
Vardenafil—Nausea—Epirubicin—hematologic cancer	1.85e-05	5.9e-05	CcSEcCtD
Vardenafil—Vomiting—Doxorubicin—hematologic cancer	1.83e-05	5.84e-05	CcSEcCtD
Vardenafil—Rash—Doxorubicin—hematologic cancer	1.82e-05	5.79e-05	CcSEcCtD
Vardenafil—Dermatitis—Doxorubicin—hematologic cancer	1.82e-05	5.78e-05	CcSEcCtD
Vardenafil—Headache—Doxorubicin—hematologic cancer	1.81e-05	5.75e-05	CcSEcCtD
Vardenafil—Nausea—Doxorubicin—hematologic cancer	1.71e-05	5.45e-05	CcSEcCtD
Vardenafil—CYP3A5—Metabolism—TXN—hematologic cancer	1.24e-05	7.81e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTO1—hematologic cancer	1.24e-05	7.81e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CB—hematologic cancer	1.24e-05	7.8e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PDGFRA—hematologic cancer	1.23e-05	7.76e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—JAK1—hematologic cancer	1.23e-05	7.73e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRKCG—hematologic cancer	1.23e-05	7.73e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3R1—hematologic cancer	1.23e-05	7.72e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EP300—hematologic cancer	1.22e-05	7.69e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK8—hematologic cancer	1.22e-05	7.69e-05	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—HRAS—hematologic cancer	1.22e-05	7.67e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—hematologic cancer	1.22e-05	7.67e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SPHK1—hematologic cancer	1.21e-05	7.64e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MAP2K1—hematologic cancer	1.21e-05	7.6e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CD—hematologic cancer	1.2e-05	7.55e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK3—hematologic cancer	1.2e-05	7.53e-05	CbGpPWpGaD
Vardenafil—PDE6G—Disease—HRAS—hematologic cancer	1.19e-05	7.52e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—JAK2—hematologic cancer	1.19e-05	7.51e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EP300—hematologic cancer	1.19e-05	7.49e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SRC—hematologic cancer	1.19e-05	7.48e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PIK3CA—hematologic cancer	1.18e-05	7.46e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2—hematologic cancer	1.18e-05	7.44e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IFNG—hematologic cancer	1.17e-05	7.37e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—UGT1A1—hematologic cancer	1.17e-05	7.34e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MYC—hematologic cancer	1.16e-05	7.33e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MDM2—hematologic cancer	1.16e-05	7.33e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—hematologic cancer	1.16e-05	7.31e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SRC—hematologic cancer	1.16e-05	7.29e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—hematologic cancer	1.16e-05	7.28e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF2—hematologic cancer	1.15e-05	7.23e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL2RA—hematologic cancer	1.15e-05	7.22e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—STAT3—hematologic cancer	1.14e-05	7.21e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NRAS—hematologic cancer	1.14e-05	7.19e-05	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—hematologic cancer	1.14e-05	7.19e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL2—hematologic cancer	1.14e-05	7.16e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CRABP1—hematologic cancer	1.13e-05	7.14e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC22A1—hematologic cancer	1.13e-05	7.14e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TERT—hematologic cancer	1.13e-05	7.14e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3R1—hematologic cancer	1.13e-05	7.13e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CB—hematologic cancer	1.13e-05	7.13e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MTOR—hematologic cancer	1.13e-05	7.13e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD4—hematologic cancer	1.13e-05	7.12e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—hematologic cancer	1.13e-05	7.1e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—STAT3—hematologic cancer	1.12e-05	7.03e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NRAS—hematologic cancer	1.11e-05	7.01e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—DCK—hematologic cancer	1.11e-05	6.99e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.11e-05	6.99e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ASNS—hematologic cancer	1.11e-05	6.99e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PDGFB—hematologic cancer	1.11e-05	6.97e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALOX5—hematologic cancer	1.1e-05	6.96e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—JAK2—hematologic cancer	1.1e-05	6.93e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—HRAS—hematologic cancer	1.1e-05	6.9e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK3—hematologic cancer	1.09e-05	6.89e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TSC2—hematologic cancer	1.08e-05	6.81e-05	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—hematologic cancer	1.07e-05	6.77e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—KRAS—hematologic cancer	1.07e-05	6.77e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MDM2—hematologic cancer	1.07e-05	6.76e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NUP98—hematologic cancer	1.07e-05	6.74e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK3—hematologic cancer	1.07e-05	6.71e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—hematologic cancer	1.06e-05	6.7e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDKN1B—hematologic cancer	1.06e-05	6.69e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—hematologic cancer	1.06e-05	6.68e-05	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—hematologic cancer	1.05e-05	6.64e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HDC—hematologic cancer	1.05e-05	6.63e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—hematologic cancer	1.05e-05	6.61e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTOR—hematologic cancer	1.04e-05	6.58e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CB—hematologic cancer	1.04e-05	6.58e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—hematologic cancer	1.04e-05	6.57e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CD4—hematologic cancer	1.04e-05	6.57e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGFR3—hematologic cancer	1.04e-05	6.55e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL2—hematologic cancer	1.04e-05	6.55e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NCOA3—hematologic cancer	1.04e-05	6.54e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ADCY7—hematologic cancer	1.04e-05	6.54e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—hematologic cancer	1.04e-05	6.53e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—hematologic cancer	1.03e-05	6.51e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NUP214—hematologic cancer	1.03e-05	6.5e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK14—hematologic cancer	1.03e-05	6.49e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—JUN—hematologic cancer	1.01e-05	6.37e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCG2—hematologic cancer	1.01e-05	6.37e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTR—hematologic cancer	1.01e-05	6.37e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ESR1—hematologic cancer	1.01e-05	6.36e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FN1—hematologic cancer	9.98e-06	6.28e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ENO2—hematologic cancer	9.91e-06	6.24e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CA—hematologic cancer	9.87e-06	6.22e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NFKBIA—hematologic cancer	9.86e-06	6.21e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BAD—hematologic cancer	9.86e-06	6.21e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—KRAS—hematologic cancer	9.83e-06	6.19e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN1B—hematologic cancer	9.8e-06	6.18e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDKN1A—hematologic cancer	9.8e-06	6.17e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PTEN—hematologic cancer	9.78e-06	6.16e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOTCH1—hematologic cancer	9.76e-06	6.15e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—hematologic cancer	9.67e-06	6.09e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CDA—hematologic cancer	9.62e-06	6.06e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTT1—hematologic cancer	9.61e-06	6.06e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—KRAS—hematologic cancer	9.58e-06	6.03e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK8—hematologic cancer	9.56e-06	6.03e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CD80—hematologic cancer	9.56e-06	6.03e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—hematologic cancer	9.55e-06	6.02e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CG—hematologic cancer	9.55e-06	6.01e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KIT—hematologic cancer	9.55e-06	6.01e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—NRAS—hematologic cancer	9.55e-06	6.01e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SDC1—hematologic cancer	9.39e-06	5.92e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTPN11—hematologic cancer	9.38e-06	5.91e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EP300—hematologic cancer	9.32e-06	5.87e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PC—hematologic cancer	9.26e-06	5.83e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—MAPK3—hematologic cancer	9.14e-06	5.76e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HRAS—hematologic cancer	9.13e-06	5.75e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CREB1—hematologic cancer	9.09e-06	5.73e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—SRC—hematologic cancer	9.07e-06	5.71e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN1A—hematologic cancer	9.05e-06	5.7e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CA—hematologic cancer	9.03e-06	5.69e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTEN—hematologic cancer	9.03e-06	5.69e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BRAF—hematologic cancer	8.97e-06	5.65e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GBA—hematologic cancer	8.94e-06	5.63e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.94e-06	5.63e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL2—hematologic cancer	8.89e-06	5.6e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6R—hematologic cancer	8.86e-06	5.58e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CREBBP—hematologic cancer	8.85e-06	5.58e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CA—hematologic cancer	8.8e-06	5.54e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—STAT3—hematologic cancer	8.74e-06	5.51e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—hematologic cancer	8.74e-06	5.51e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—hematologic cancer	8.73e-06	5.5e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—NRAS—hematologic cancer	8.72e-06	5.5e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EP300—hematologic cancer	8.61e-06	5.42e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—hematologic cancer	8.51e-06	5.36e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAP2K1—hematologic cancer	8.45e-06	5.32e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CD—hematologic cancer	8.39e-06	5.29e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SRC—hematologic cancer	8.37e-06	5.27e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK3—hematologic cancer	8.35e-06	5.26e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HRAS—hematologic cancer	8.35e-06	5.26e-05	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CA—hematologic cancer	8.31e-06	5.24e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—KRAS—hematologic cancer	8.22e-06	5.18e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTAP—hematologic cancer	8.18e-06	5.15e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HRAS—hematologic cancer	8.14e-06	5.13e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—STAT3—hematologic cancer	8.07e-06	5.09e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—hematologic cancer	8.06e-06	5.08e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NRAS—hematologic cancer	8.05e-06	5.07e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF2—hematologic cancer	8.04e-06	5.06e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—hematologic cancer	8e-06	5.04e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CD44—hematologic cancer	7.99e-06	5.03e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NQO1—hematologic cancer	7.99e-06	5.03e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3R1—hematologic cancer	7.92e-06	4.99e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—hematologic cancer	7.79e-06	4.91e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MAPK3—hematologic cancer	7.71e-06	4.86e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—JAK2—hematologic cancer	7.7e-06	4.85e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYCS—hematologic cancer	7.56e-06	4.76e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CA—hematologic cancer	7.55e-06	4.76e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MDM2—hematologic cancer	7.52e-06	4.74e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	7.51e-06	4.73e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—KRAS—hematologic cancer	7.51e-06	4.73e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—hematologic cancer	7.5e-06	4.73e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—hematologic cancer	7.48e-06	4.71e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—hematologic cancer	7.38e-06	4.65e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MTOR—hematologic cancer	7.32e-06	4.61e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CB—hematologic cancer	7.32e-06	4.61e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—FHL2—hematologic cancer	7.29e-06	4.59e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—hematologic cancer	7.19e-06	4.53e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AGRN—hematologic cancer	7.15e-06	4.5e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HRAS—hematologic cancer	6.98e-06	4.4e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—KRAS—hematologic cancer	6.93e-06	4.37e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CA—hematologic cancer	6.9e-06	4.35e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN1B—hematologic cancer	6.86e-06	4.33e-05	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—hematologic cancer	6.79e-06	4.28e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMMR—hematologic cancer	6.78e-06	4.27e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—IDH2—hematologic cancer	6.78e-06	4.27e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CASP3—hematologic cancer	6.73e-06	4.24e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL2—hematologic cancer	6.72e-06	4.23e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—hematologic cancer	6.68e-06	4.21e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTP1—hematologic cancer	6.66e-06	4.2e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCND1—hematologic cancer	6.55e-06	4.13e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—JUN—hematologic cancer	6.54e-06	4.12e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HRAS—hematologic cancer	6.38e-06	4.02e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.37e-06	4.01e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CA—hematologic cancer	6.37e-06	4.01e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN1A—hematologic cancer	6.34e-06	3.99e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTEN—hematologic cancer	6.32e-06	3.98e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCB1—hematologic cancer	6.31e-06	3.97e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA9—hematologic cancer	6.2e-06	3.91e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACP5—hematologic cancer	6.2e-06	3.91e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK8—hematologic cancer	6.18e-06	3.9e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—hematologic cancer	6.17e-06	3.89e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTM1—hematologic cancer	6.12e-06	3.86e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NCOR1—hematologic cancer	6.12e-06	3.86e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.12e-06	3.85e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—hematologic cancer	6.11e-06	3.85e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EP300—hematologic cancer	6.03e-06	3.8e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HRAS—hematologic cancer	5.89e-06	3.71e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SRC—hematologic cancer	5.86e-06	3.69e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—IDH1—hematologic cancer	5.83e-06	3.67e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TXN—hematologic cancer	5.76e-06	3.63e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.76e-06	3.63e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.76e-06	3.63e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—hematologic cancer	5.71e-06	3.6e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STAT3—hematologic cancer	5.65e-06	3.56e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.64e-06	3.55e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NRAS—hematologic cancer	5.64e-06	3.55e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—hematologic cancer	5.64e-06	3.55e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—hematologic cancer	5.63e-06	3.55e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.42e-06	3.41e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—hematologic cancer	5.41e-06	3.41e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK3—hematologic cancer	5.4e-06	3.4e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.27e-06	3.32e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.27e-06	3.32e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—hematologic cancer	5.25e-06	3.31e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—hematologic cancer	5.24e-06	3.3e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—hematologic cancer	5.2e-06	3.28e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.14e-06	3.24e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NUP98—hematologic cancer	4.97e-06	3.13e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KRAS—hematologic cancer	4.85e-06	3.06e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.83e-06	3.04e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.83e-06	3.04e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NUP214—hematologic cancer	4.8e-06	3.02e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTR—hematologic cancer	4.7e-06	2.96e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.7e-06	2.96e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ENO2—hematologic cancer	4.61e-06	2.9e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CG—hematologic cancer	4.55e-06	2.86e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.47e-06	2.82e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CA—hematologic cancer	4.46e-06	2.81e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SDC1—hematologic cancer	4.37e-06	2.75e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—hematologic cancer	4.31e-06	2.72e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CREBBP—hematologic cancer	4.22e-06	2.66e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HRAS—hematologic cancer	4.13e-06	2.6e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CD—hematologic cancer	4e-06	2.52e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—hematologic cancer	3.95e-06	2.49e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALB—hematologic cancer	3.95e-06	2.49e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3R1—hematologic cancer	3.77e-06	2.38e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NQO1—hematologic cancer	3.71e-06	2.34e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CD44—hematologic cancer	3.71e-06	2.34e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—hematologic cancer	3.64e-06	2.3e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYCS—hematologic cancer	3.51e-06	2.21e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.49e-06	2.2e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CB—hematologic cancer	3.48e-06	2.19e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.1e-06	1.95e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTEN—hematologic cancer	3.01e-06	1.9e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.93e-06	1.85e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—EP300—hematologic cancer	2.87e-06	1.81e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.85e-06	1.79e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.85e-06	1.79e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.52e-06	1.58e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.12e-06	1.34e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.11e-06	1.33e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.96e-06	1.23e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.86e-06	1.17e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALB—hematologic cancer	1.83e-06	1.16e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.75e-06	1.11e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—hematologic cancer	1.73e-06	1.09e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.62e-06	1.02e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTEN—hematologic cancer	1.4e-06	8.82e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—EP300—hematologic cancer	1.33e-06	8.41e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.87e-07	6.22e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—hematologic cancer	8.07e-07	5.08e-06	CbGpPWpGaD
